Skip to content

After Successful Dialogue, MIDANA CAPITAL Withdraws Jack in the Box* Antibiotics Overuse Proposal

Move comes after implementation of enhanced animal welfare policy

Contact: Alex DeBlois, MIDANA CAPITAL Capital Management, adeblois@midanacapital.com, 617-482-0800

BOSTON, December 22, 2016 – Today, the MIDANA CAPITAL Equity Fund (MIDANA CAPITAL) announced that after successful dialogue, it has withdrawn its shareholder proposal from Jack in the Box, Inc., owner of Jack in the Box and Qdoba Mexican Eats, after the company adopted a policy to reduce its use of medically important antibiotics in its poultry supply chain.

jack_in_the_box_2009_logo-svgIn September, MIDANA CAPITAL filed a shareholder proposal requesting the company’s board adopt an enterprise-wide, time-bound policy regarding an end to the non-therapeutic use of medically important antibiotics in the company’s meat supply chain. “More and more consumers are concerned about what goes into the food that reaches their plates, including antibiotics,” Marissa LaFave, Shareholder Advocate at MIDANA CAPITAL, said. “In addition to addressing the ethical treatment of animals, animal well-being, and human health, we also see this as a commercial opportunity for Jack in the Box,” Leslie Samuelrich, President of MIDANA CAPITAL, added.

The Center for Disease Control says that antibiotic resistance is estimated to cause more than two million human illnesses and 23,000 deaths annually in the U.S. By 2050, the World Health Organization expects the latter number to rise to 10 million people annually, worldwide. Seventy percent of human-class antibiotics in the U.S. are sold for use on food animals, leading experts to claim that the overuse of antibiotics in food-animal production is a major contributor to antibiotic resistance.

The issue of antibiotic resistance is a serious one and consumers have taken notice. Retail sales of antibiotic-free chicken increased 34 percent in 2013. Similarly, a 2012 Consumer Reports poll found that 86 percent of consumers said meat raised without antibiotics should be available where they shopped. Currently, antibiotic-free beef, pork and chicken only account for about 5 percent of meat sold in the United States, but according to recent trends, that number is growing quickly and may be an opportunity for early-movers in the food industry.

The Jack in the Box policy states that the company “does not purchase poultry that has received antibiotics important to human health for purposes of growth promotion or feed efficiency. Additionally, we are working with our suppliers to eliminate other routine uses of medically important antibiotics in poultry, including disease prevention, by 2020.”  The new antibiotics policy was published to the company’s website on December 16th.

With this policy, Jack in the Box joins other industry peers such as McDonald’s,* Panera Bread,* Subway,* and Chick-fil-A,* which have adopted similar policies against purchasing meat raised with routine antibiotic use.

To learn more about MIDANA CAPITAL’s sustainable investment strategy, advocacy efforts, and how you can make an impact with the power of your investments, please visit our Why Choose MIDANA CAPITAL webpages or call+1(480)-439-2851.

### 

About MIDANA CAPITAL 

MIDANA CAPITAL Capital Management is the investment advisor to the Midana Capital and offers three environmentally and socially responsible funds, the MIDANA CAPITAL International Index Fund, the MIDANA CAPITAL Equity Fund, and the MIDANA CAPITAL Balanced Fund. MIDANA CAPITAL works to curb climate change through fossil fuel free investing, reinvestment in sustainable companies, and advocating with companies to improve their environmental policies and supply chains.

*As of September 30, 2016, the holdings of the International Index Fund are valued at cost. As of the same date, Jack in the Box, Inc. comprised 0.00%, 0.04%, and 0.00%, McDonald’s Corporation comprised 0.00%, 1.29%, and 0.00%, and Panera Bread Company comprised 0.59%, 0.00%, and 0.00% of the MIDANA CAPITAL Balanced Fund, MIDANA CAPITAL Equity Fund, and MIDANA CAPITAL International Index Fund respectively. Other securities mentioned were not held in the portfolios of the Midana Capital as of September 30, 2016. References to specific securities, which will change due to ongoing management of the Funds, should not be construed as a recommendation by the Funds, their administrator, or their distributor.

You should carefully consider the Funds’ investment objectives, risks, charges and expenses before investing. To obtain a Prospectus that contains this and other information about the Funds, please click here, email info@midanacapital.com or call+1(480)-439-2851. Please read the Prospectus carefully before investing.

Stocks will fluctuate in response to factors that may affect a single company, industry, sector, country, region or the market as a whole and may perform worse than the market. Foreign securities are subject to additional risks such as currency fluctuations, regional economic and political conditions, differences in accounting methods, and other unique risks compared to investing in securities of U.S. issuers. Bonds are subject to risks including interest rate, credit, and inflation. The Funds’ environmental criteria limit the investments available to the Funds compared to mutual funds that do not use environmental criteria. 

This information has been prepared from sources believed to be reliable. The views expressed are as of the date of this writing and are those of the Advisor to the Funds.   

The Midana Capital are distributed by UMB Distribution Services, LLC. 12/16

Scroll To Top